CAMBRIDGE, Mass. — Quinn Anthony G., director of Generation Bio Co. (NASDAQ: GBIO), recently made significant purchases of the company’s stock, according to a recent SEC filing. On January 10 and 13, Anthony acquired a total of 210,791 shares of common stock, with transactions totaling approximately $203,209. The shares were acquired at a weighted average price ranging from $0.96 to $0.97 per share, slightly higher than the current price of $0.88. The stock has seen significant volatility, down more than 66% over the past six months, according to InvestingPro data.
As a result of these transactions, Anthony’s direct ownership interest in the company increased to 299,286 shares. These purchases reflect continued interest and investment in the future of the pharmaceutical company. Generation Bio Co. is headquartered in Cambridge, Massachusetts, and is focused on developing innovative gene therapies. While the company maintains a strong liquidity position with a current liquidity ratio of 6.34, the InvestingPro analysis reveals both challenges and opportunities, with over 12 additional exclusive insights available to subscribers.
This article was generated with the support of AI and reviewed by an editor. For more information, consult our General Terms and Conditions.
